NanoViricides, Inc. (NNVC)

NanoViricides Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1.13	1.56	4.8	8.15	14.07	20.52
Cash & Short-Term Investments	1.13	1.56	4.8	8.15	14.07	20.52
Cash Growth	-70.88%	-67.52%	-41.13%	-42.06%	-31.44%	49.66%
Prepaid Expenses	0.13	0.11	0.17	0.3	0.35	0.31
Total Current Assets	1.25	1.67	4.97	8.45	14.42	20.82
Property, Plant & Equipment	6.79	6.83	7.51	8.11	8.69	9.08
Other Intangible Assets	0.31	0.32	0.33	0.33	0.34	0.35
Other Long-Term Assets	0	0	0.01	0.01	0.04	0
Total Assets	8.36	8.82	12.82	16.9	23.49	30.26
Accounts Payable	0.25	0.46	0.38	0.16	0.06	0.2
Accrued Expenses	0.03	0.03	0.26	0.14	0.05	0.02
Short-Term Debt	-	-	-	-	0.09	0.1
Other Current Liabilities	0.9	0.82	0.72	0.23	0.21	0.03
Total Current Liabilities	1.18	1.31	1.36	0.53	0.41	0.35
Other Long-Term Liabilities	-	-	-	1.5	-	-
Total Liabilities	1.18	1.31	1.36	2.03	0.41	0.35
Common Stock	0	0	0	0	0	0.01
Additional Paid-In Capital	157.8	156.36	150.84	145.95	145.57	144.28
Retained Earnings	-150.63	-148.84	-139.37	-131.08	-122.49	-114.39
Total Common Equity	7.17	7.52	11.46	14.87	23.08	29.91
Shareholders' Equity	7.17	7.52	11.46	14.87	23.08	29.91
Total Liabilities & Equity	8.36	8.82	12.82	16.9	23.49	30.26
Total Debt	-	-	-	-	0.09	0.1
Net Cash (Debt)	1.13	1.56	4.8	8.15	13.97	20.42
Net Cash Growth	-70.88%	-67.52%	-41.13%	-41.67%	-31.58%	62.54%
Net Cash Per Share	0.07	0.10	0.40	0.70	1.21	1.87
Filing Date Shares Outstanding	18	17.43	14.68	11.75	11.59	11.52
Total Common Shares Outstanding	17.56	16.61	13.14	11.7	11.59	11.52
Working Capital	0.07	0.36	3.61	7.91	14	20.47
Book Value Per Share	0.41	0.45	0.87	1.27	1.99	2.60
Tangible Book Value	6.86	7.2	11.14	14.53	22.74	29.56
Tangible Book Value Per Share	0.39	0.43	0.85	1.24	1.96	2.57
Land	0.26	0.26	0.26	0.26	0.26	0.26
Machinery	6.6	6.6	6.54	6.38	6.25	6.05

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q